CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING
CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING
批准号:
6373572
负责人:
KE ZHANG
金额:
$10.38万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2002-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the investigator's abstract) The overall
objective of this proposal is to elucidate a critical process in
immunoglobulin (Ig) isotype switching: the mechanism by which the
specificity of Ig isotype switch is determined and ultimately achieved. We
will test the hypothesis that chimeric Ig germline mRNA transcripts serve as
the specific templates that determine the specificity of Ig class switch
recombination with emphasis on switching to IgE. We have shown that such
chimeric mRNA are derived from trans-splicing of germline Ig pre-mRNAs of C
mu and the germline pre-mRNAs of downstream isotype(s). These chimeric Ig
germline mRNAs, by Hoogsteen base-pairing to their corresponding double
stranded DNA region, are ideal templates to function as "bridging
templates". This bridging will bring mu switch and the involved downstream
isotype switch regions in close proximity and thereby direct Ig switch
recombination. To test this hypothesis, we will determine in human primary
B cells whether transfection of constructs producing specific chimeric Ig
germline MRNA transcripts in anti-sense orientation blocks specific Ig
switching recombination and isotype production and whether transfection of
chimeric Ig germline MRNA in sense orientation specifically enhances switch
recombination and Ig production. We will quantitatively determine the
kinetics of appearance of chimeric Ig germline MRNA transcripts and their
relationship to Ig isotype switching. To better define the role of chimeric
Ig germline transcripts in Ig switching, we will determine the ability of
known switch signals to regulate trans-splicing and the resulting production
of chimeric Ig germline MRNAS. As the selection and pattern of switch
recombination sites (i.e. primary vs. secondary recombination) has important
implications for Ig isotype production and stabilization, we will extend our
hypothesis by testing if the specific structure of chimeric Ig germline
transcripts (3'-5' vs 5'-3' chimeras) have distinct abilities to mediate
primary or secondary recombination predicting that 3'-5' chimeras (e.g. I
epsilon-C mu transcripts) will mediate primary recombination whereas 5'-3'
chimeras (e.g. I mu-C epsilon transcripts) will mediate secondary
recombination. Finally, we will test the hypothesis that repetitive G bases
in RNA ("G4-RNA") as found in Ig switch regions plays a key role in
promoting the trans-splicing of Ig germline pre-mRNA transcripts. Employing
a cell free in vitro splicing system, we will analyze the effects of G4-RNA
formation on Ig trans-splicing. Furthermore we will determine the ability
of chimeric Ig germline mRNAs to pair in vitro to the corresponding region
of double stranded DNA through Hoogsteen base pairing.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
CD40-mediated p38 mitogen-activated protein kinase activation is required for immunoglobulin class switch recombination to IgE.
CD40 介导的 p38 丝裂原激活蛋白激酶激活是免疫球蛋白类别转换重组为 IgE 所必需的。
DOI:
10.1067/mai.2002.126382
发表时间:
2002
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Zhang,Ke, Zhang,Ling, Zhu,Daocheng, Bae,David, Nel,Andre, Saxon,Andrew]
通讯作者:
Saxon,Andrew
Accessibility control and machinery of immunoglobulin class switch recombination.
免疫球蛋白类开关重组的可及性控制和机制。
DOI:
10.1189/jlb.0702339
发表时间:
2003
期刊:
Journal of leukocyte biology
影响因子:
5.5
作者:
[Zhang,Ke]
通讯作者:
Zhang,Ke
Targeting surface-bound IgE as a novel allergy therapeutic
-
批准号:9089826
-
项目类别:
-
资助金额:$73.97万
-
财政年份:2014
-
负责人:KE ZHANG
-
依托单位:
IgE-guided RNAi silencing of FceRIb expression as a novel allergy therapeutic
-
批准号:8283505
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2012
-
负责人:KE ZHANG
-
依托单位:
IgE-guided RNAi silencing of FceRIb expression as a novel allergy therapeutic
-
批准号:8519292
-
项目类别:
-
资助金额:$18.1万
-
财政年份:2012
-
负责人:KE ZHANG
-
依托单位:
BIOINFORMATICS CORE
-
批准号:8360061
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2011
-
负责人:KE ZHANG
-
依托单位:
BIOINFORMATICS CORE
-
批准号:8167924
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2010
-
负责人:KE ZHANG
-
依托单位:
SECOND GENERATION MULTILAYER ANALYZER ARRAY DETECTOR
-
批准号:7369171
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2006
-
负责人:KE ZHANG
-
依托单位:
Impact of Anti-IL-4 Therapy on Immune Polarization
-
批准号:6592917
-
项目类别:
-
资助金额:$10.87万
-
财政年份:2002
-
负责人:KE ZHANG
-
依托单位:
Impact of Anti-IL-4 Therapy on Immune Polarization
-
批准号:6660320
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2002
-
负责人:KE ZHANG
-
依托单位:
MULTILAYER ANALYSER FOR XAFS: X RAY FLUORESCENCE DETECTOR
-
批准号:6316852
-
项目类别:
-
资助金额:$10.86万
-
财政年份:1999
-
负责人:KE ZHANG
-
依托单位:--
TIME RESOLVED XAFS & OPTICAL MONITORING
-
批准号:6315746
-
项目类别:
-
资助金额:$6.03万
-
财政年份:1999
-
负责人:KE ZHANG
-
依托单位:--
TIME RESOLVED XAFS & OPTICAL MONITORING
-
批准号:6316853
-
项目类别:
-
资助金额:$6.03万
-
财政年份:1999
-
负责人:KE ZHANG
-
依托单位:--
MULTILAYER ANALYSER FOR XAFS: X RAY FLUORESCENCE DETECTOR
-
批准号:6315745
-
项目类别:
-
资助金额:$10.86万
-
财政年份:1999
-
负责人:KE ZHANG
-
依托单位:--
BIOCAT MULTILAYER ANALYZER
-
批准号:6122946
-
项目类别:
-
资助金额:$2.3万
-
财政年份:1998
-
负责人:KE ZHANG
-
依托单位:
BIOCAT MULTILAYER ANALYZER
-
批准号:6282941
-
项目类别:
-
资助金额:$4.19万
-
财政年份:1998
-
负责人:KE ZHANG
-
依托单位:
CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING
-
批准号:2005119
-
项目类别:
-
资助金额:$10.59万
-
财政年份:1997
-
负责人:KE ZHANG
-
依托单位:
CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING
-
批准号:6170305
-
项目类别:
-
资助金额:$10.47万
-
财政年份:1997
-
负责人:KE ZHANG
-
依托单位:
CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING
-
批准号:2887330
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1997
-
负责人:KE ZHANG
-
依托单位:
CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING
-
批准号:2672891
-
项目类别:
-
资助金额:$10.57万
-
财政年份:1997
-
负责人:KE ZHANG
-
依托单位:
海外基金